oral semaglutide phase 3 According to The Conversation, a new once-daily weight-loss pill called orforglipron showed stronger results than leading in a major trial, helping participants lose more weight and improve blood In the OASIS 4 phase

GLP-1 AND THE WORKPLACE STUDY: Researchers in Indianapolis are launching a first of its kind study about the impact of GLP-1s on the workplace

A UNC Health endocrinologist explains the long-term effects on hunger and weight.

GLP-1 Receptor Agonists and Thyroid Cancer Risk: What the Evidence Really Shows As GLP-1RAs revolutionise diabetes and obesity treatment, concerns about thyroid cancer persist

This includes 6% who say they are currently taking one of the drugs.

Mensen die bariatrische chirurgie hebben ondergaan

Originally developed to help people with type 2 diabetes manage blood sugar, the drug semaglutide, commonly known by the brand names Ozempic or Wegovy, has shown promise for other health issues as well